Slide 2
ACRO Members Create New Framework to Advance Decentralized Clinical Trials

The Decentralized Clinical Trials (DCT) Working Party publishes quality-based principles and risk assessment considerations for patient-focused decentralization of clinical trials.

Slide Image
Slide 1
Risk-based Monitoring in Clinical Trials: Past, Present & Future

The Risk-Based Quality Management (RBQM) Working Group releases new report showcasing changes in the RBQM landscape.

Slide Image

Responses and Resources for COVID-19

Click here for ACRO’s latest statements on the COVID-19 pandemic.

ACRO News

Read about ACRO’s initiatives, COVID-19 efforts, and more.

Member Innovation Hub

Take a look at how our members are innovating in top focus areas.

US Regulatory Policy

Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »

European Advocacy

ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »

CRO Forum

ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »

Clinical Research Roundtables

In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »

Addressing Industry Pain Points

We help create a predictable, enabling business environment. ACRO’s proactive agenda is focused on policy outcomes that advance specific operational interests of ACRO members. More »

Data Protection & Privacy

ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »

Subscribe

Get ACRO’s free quarterly newsletter to stay informed about our work and the industry.

    News and Comments

    Press Releases

    ACRO Applauds Release of Cures 2.0 Draft Legislation

    June 23, 2021

    Washington, DC — The Association of Clinical Research Organizations (ACRO) congratulates Representatives Diana DeGette (D-CO) and Fred Upton (R-MI) on the release…

    Press Releases

    ACRO Releases New Report on the Past, Present, and Future of Risk-Based Monitoring

    May 4, 2021

    Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial…

    Press Releases

    2021 Officers and New Member Announcement

    December 17, 2020

    Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Steve…

    COVID-19Lessons Learned

    Warping the speed of vaccine development

    November 30, 2020

    Ironically, the Pfizer-BioNTech Covid-19 vaccine program did not take “Operation Warp Speed” funding. Even more ironic is the fact that Pfizer got…

    COVID-19Lessons Learned

    A ‘Holy Grail Moment’ for Clinical Research

    November 23, 2020

    It was a familiar scenario: A rare disease area of oncology. A new drug candidate. A desire to assess efficacy as safely and quickly as possible, so that if successful, a new therapy could get approved and change lives. But this desire could have been tempered by reality: the trial was going to be challenging and slow…

    COVID-19Lessons Learned

    Seeing progress through the eyes of patients

    November 20, 2020

    For the clinical research industry, technological tools improve trial continuity, and generate data that helps power more robust monitoring of safety and quality. They can also be a natural fit for patients. IQVIA also sees study participants liking the direct shipment of medicines, telehealth interactions and at-home visits. In the COVID era and beyond, designing more trials with these kinds of technology-enabled strategies is going to help more people by lowering barriers to participation, and speeding the development of new medicines.

    Join ACRO and Add Your Voice

    We help create a global regulatory and business environment
    where ACRO members succeed

    ACRO Members